Aspira Women’s Health (NASDAQ:AWH – Get Free Report) posted its earnings results on Thursday. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.13, Zacks reports.
Aspira Women’s Health Price Performance
Aspira Women’s Health stock traded up $0.01 during mid-day trading on Thursday, hitting $0.11. The company’s stock had a trading volume of 2,281,747 shares, compared to its average volume of 1,153,391. The company has a market cap of $1.94 million, a PE ratio of -0.09 and a beta of 1.57. The firm’s 50 day moving average is $0.26 and its 200 day moving average is $0.61. Aspira Women’s Health has a 52-week low of $0.08 and a 52-week high of $3.68.
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on Aspira Women’s Health in a report on Sunday, January 12th. They issued a “hold” rating on the stock.
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
See Also
- Five stocks we like better than Aspira Women’s Health
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Top 3 Beverage Stocks Pouring Out Profits
- 3 Best Fintech Stocks for a Portfolio Boost
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.
